Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human umbilical cord-derived mesenchymal stem cells (Sun Yat-sen University)
- Development stage
- Unknown
- Lead developer
- Sun Yat-sen University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intra-arterial
01
Overview
Human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are an investigational allogeneic cell therapy being evaluated for the prevention and treatment of delayed graft function (DGF) and acute rejection in renal transplant recipients. This specific clinical program is led by Dr. Qipeng Sun at The Third Affiliated Hospital of Sun Yat-sen University. The therapy utilizes the immunomodulatory, anti-inflammatory, and regenerative properties of stem cells harvested from the Wharton's jelly of the umbilical cord. The biological mechanism involves the secretion of paracrine factors and direct cell-to-cell interactions that suppress the host's immune response and facilitate the repair of ischemia-reperfusion injury in the transplanted organ. In clinical trials, the cells are administered via a dual-route induction regimen consisting of an intravenous infusion prior to transplantation and a direct injection into the renal artery following the procedure.
- Other names
- UC-MSCshUC-MSCsumbilical cord-derived mesenchymal stem cells
Beyond the preview
Go deeper on human umbilical cord-derived mesenchymal stem cells (Sun Yat-sen University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human umbilical cord-derived mesenchymal stem cells (Sun Yat-sen University).